SEC Form D private-offering filing

Acurx Pharmaceuticals, Inc.

Name: Acurx Pharmaceuticals, Inc. - new SEC Form D private-offering filing, Staten Island, NY
Published: 2026-04-29

A new SEC Form D private-offering notice from Staten Island, NY, a $4,587,473 filer-stated offering target in Biotech. The source filing is one click away.

Acurx Pharmaceuticals, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing novel antibiotics for drug resistant infections, lead candidate ibezapolstat targets C. difficile

Filed 2026-04-29Filed to raise $4,587,473First money in 2026-04-15Raised so far $4,587,473HQ (as filed) Staten Island, NYSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified acurxpharma.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.